DermTech, Inc. (DMTKQ) vs XWELL, Inc. (XWEL)
- DermTech, Inc. DMTKQ 0.00 NaN
- XWELL, Inc. XWEL 0.73 −2.67%
DermTech, Inc. and XWELL, Inc. are both Diagnostics & Research companies. XWELL, Inc. is the larger, with a market value of $7.5M against $3.3M — 2.3× the size. DermTech, Inc. grew revenue faster over the last twelve months: 9.71% against −7.58%. XWELL, Inc. has the higher net margin (−117.8% vs −572.2%) and the higher return on invested capital (0.00% vs −5,493.5%). Across the 17 metrics below, DermTech, Inc. leads on 9 and XWELL, Inc. on 8.
Valuation
Profitability
| Metric | DMTKQ | XWEL | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 8.51% | 34.34% | 50.89% |
| Operating margin | (588.62%) | (61.31%) | (8.57%) |
| Net margin | (572.19%) | (117.83%) | (6.37%) |
| Free cash flow margin | (460.10%) | (47.65%) | 0.00% |
| Return on equity | (121.75%) | (557.21%) | (2.92%) |
| Return on assets | (64.00%) | (155.10%) | (6.71%) |
| Return on invested capital | (5,493.45%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack